Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119625) titled 'The half effective concentration of TCI of cyclophosphamide in patients with neoadjuvant chemotherapy for breast cancer during intubation' on March 2.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Affiated Cancer Hospital of Guizhou Medical University
Condition:
Radical mastectomy for breast cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-02
Target Sample Size: Experimental group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=311683
Published by HT Digital Content Services...